Phio Pharmaceuticals to Present Clinical Development Update and Upcoming Catalysts at Life Sciences Future 2026 Conference

Company to Highlight Next Stage of PH-762 Clinical Development in Cutaneous Squamous Cell CarcinomaKing of Prussia, Pennsylvania--(. - September 23, 2026) - Phio Pharmaceuticals Corp. NASDAQ:PHIO, a clinical-stage biopharmaceutical company developing therapeutics using its proprietary…